5Zhao YH,Zou YG,Sun OJ ,et al. Treatment of hyper lipidemia with a modified low density lipoprotein apheresis system with dextran sulfate[J]. Ther Apher Dial, 2007,11 : 249-54.
二级参考文献28
1[1]Seidel H.E.L.P. Apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs,1996, 20: 303-310
2[2]Kroon AA, Acngevaeren WRM, Vander Werf T, et al. LDL - a-pheresis atherosclerosis regression study (LAARS) .Circulation, 1996, 93:1826-1835
3[3]Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation, 1995, 92:657 - 671
4[4]Schuff - Werner P. Schettler V. Plaque stabilization by LDL - a-pheresis? Heart, 1999, 24: 57- 61
5[5]Kowal P, Walzl M, Walzl B, et al. The influence of the H. E. L.P.system on yield shear stress in vascular disease. Clin .Hemorheol, 1993, 13: 701- 706
6[6]Tamai O, matusuoka H, Itabe H, et al. Single LDL apheresis improves endothelium - dependant vasodilatation in hypercholesterolemia humans. Circulation, 1997, 95: 76 - 82
7[7]Hahnel D, Thiery J, Brosche T, et al. The role of plasmalogens in the enhanced resistance of LDL against copper induced oxidation after LDL apheresis. Arterioscler Thromb Vasc Biol. 1999, 19:2431-2438
8[8]Deckeri V, Brunel A, Lantoine F, et al. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler Thromb Vasc Biol, 1998, 18: 1054- 1060
9[9]Mellwig KP, Bailer D, Gleichmann U, et al. Improvement of coronary vasodilatation capacity through single LDLapheresis. Atherosclerosis, 1998, 139: 173- 178
10[10]Walzl M, Valetitsch H, Walzl B, et al. Improvement cerebral blood flow in patients treated by a single heparin - induced extracorporeal LDL precipitation (HELP) . Clin Hemorheol, 1994,14:27-35
